Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 471Neoplasms 328Colorectal Neoplasms 235Carcinoma, Non-Small-Cell Lung 234Lung Neoplasms 200Prostatic Neoplasms 179Carcinoma, Hepatocellular 174Stomach Neoplasms 138Pancreatic Neoplasms 126Leukemia, Myeloid, Acute 114Uterine Cervical Neoplasms 110Rectal Neoplasms 105Multiple Myeloma 94Recurrence 89Squamous Cell Carcinoma of Head and Neck 84Head and Neck Neoplasms 79Neoplasm Metastasis 76Ovarian Neoplasms 75Brain Neoplasms 71Colonic Neoplasms 68Glioblastoma 67Esophageal Neoplasms 66Triple Negative Breast Neoplasms 65Endometrial Neoplasms 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Small Cell Lung Carcinoma 54Disease 54Motor Activity 53Hematologic Neoplasms 53Glioma 48

Interventions

Specimen Handling 1Magnetic Resonance Spectroscopy 1Clinical Protocols 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Advanced Hormone Receptor-Positive Breast Carcinoma × Clear all
NCT07590583 2026-05-15

Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial

City of Hope Medical Center

Phase 1 Not yet recruiting
20 enrolled
Breast

Advanced Hormone Receptor-Positive Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡